Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer-single institutional experience-论文-万方医学网

首页> > Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer-single institutional experience

Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer-single institutional experience

导出原文传递

翻译打印收藏纠错

第一作者： Okunaka, Mashiro

作者： Okunaka, Mashiro ; Kawazoe, Akihito ; Nakamura, Hitomi ; Kotani, Daisuke ; Mishima, Saori ; Kuboki, Yasutoshi ; Nakamura, Yoshiaki ; Shitara, Kohei

关键词 Trifluridine/tipiracil plus ramucirumab Trifluridine/tipiracil monotherapy Advanced gastric cancer OPEN-LABEL GASTROESOPHAGEAL JUNCTION CHEMOTHERAPY TAS-102 PACLITAXEL CARCINOMA BIOMARKER AGENT

发布时间 2024-04-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer-single institutional experience

相似文献

同项目论文

相关期刊

检索历史 清除

Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer-single institutional experience

相似文献

同项目论文

相关期刊

检索历史清除